Anju Software, a life sciences software platform backed by Providence Equity Partners, has acquired MDCPartners, company that specializes in business intelligence data solutions for clinical trial optimization, medical expert identification and competitive intelligence.
- This acquisition strengthens Anju’s current product portfolio and can now provide up-to-date comprehensive data for Medical Expert Engagement and Clinical Trial Optimization
- MDC, which is based in Belgium, also provides operations in Europe to better service global customers
About Anju Software
Anju Software is a leading provider of comprehensive software solutions to the life sciences industry. Anju provides an integrated platform spanning clinical, medical affairs and commercial operations. Anju solutions are used by large and small pharmaceutical companies, clinical research organizations (CRO), full service agencies and medical device companies. Data flow between functional areas, seamless communication with third party systems and AI-based data mining solutions to provide customers critical information throughout their ecosystem.
About MDCPartners
MDCPartners provides business intelligence solutions for clinical trial optimization, medical expert identification and competitive intelligence. With deep expertise in the fields of data mining, semantic processing and engineering, MDC provides its clients with event-based tools to monitor and analyze an ever-expanding world of public and private data. MDC combines its expertise in drug development processes with its unique IT architecture to provide cost effective information solutions to the pharmaceutical and biotech industry.
About Providence Strategic Growth
Providence is a premier asset management firm with over $40 billion in aggregate capital commitments. Providence pioneered a sector-focused approach to private equity investing with the vision that a dedicated team of industry experts could build exceptional companies of enduring value. Since the firm’s inception in 1989, Providence has invested in over 180 companies and has become a leading equity investment firm focused on the media, communications, education and information industries.
Client Highlights
- 9 Transactions
- 6 Years of Partnership
Transaction Details
-
SectorsHealthcare & Life Sciences Technologies
-
ServiceM&A
-
OwnershipInvestor-Backed
-
PracticesHealthcare & Life Sciences TechnologySponsor Coverage